These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 33773121)

  • 21. COVID-19 in Pakistan: Impact on global polio eradication initiative.
    Haqqi A; Zahoor S; Aftab MN; Tipu I; Rehman Y; Ahmed H; Afzal MS
    J Med Virol; 2021 Jan; 93(1):141-143. PubMed ID: 32603503
    [No Abstract]   [Full Text] [Related]  

  • 22. How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    Reid M; Abdool-Karim Q; Geng E; Goosby E
    PLoS Med; 2021 Mar; 18(3):e1003564. PubMed ID: 33705396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease 2019 and clinical research in U.S. nursing homes.
    Quinn CC; Adams AS; Magaziner JS; Gurwitz JH
    J Am Geriatr Soc; 2021 Jul; 69(7):1748-1751. PubMed ID: 33872385
    [No Abstract]   [Full Text] [Related]  

  • 24. World Health Assembly 73: A Step Forward for Global Surgery.
    Cahill GL; Stankey MC; McClain CD; Park KB
    Ann Glob Health; 2021 Feb; 87(1):17. PubMed ID: 33633928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: Lessons from the COVID-19 global health response to inform TB case finding.
    Oga-Omenka C; Tseja-Akinrin A; Boffa J; Heitkamp P; Pai M; Zarowsky C
    Healthc (Amst); 2021 Jun; 9(2):100487. PubMed ID: 33607520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA.
    Khatana SAM; Groeneveld PW
    J Gen Intern Med; 2020 Aug; 35(8):2431-2432. PubMed ID: 32462564
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenges in TB control and the anticipated COVID-19 third wave: Way forward.
    Padmapriyadarsini C; Banurekha V; Arora VK
    Indian J Tuberc; 2021 Oct; 68(4):425-427. PubMed ID: 34752307
    [No Abstract]   [Full Text] [Related]  

  • 28. Certifying Guinea worm eradication: current challenges.
    Molyneux DH; Eberhard ML; Cleaveland S; Addey R; Guiguemdé RT; Kumar A; Magnussen P; Breman JG
    Lancet; 2020 Dec; 396(10265):1857-1860. PubMed ID: 33278938
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards universal health coverage: a health workforce fit for purpose and practice.
    Campbell J
    Bull World Health Organ; 2013 Nov; 91(11):887-8. PubMed ID: 24347716
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of second wave of Covid-19 on tuberculosis control.
    Chopra KK; Matta S; Arora VK
    Indian J Tuberc; 2021 Jul; 68(3):311-312. PubMed ID: 34099194
    [No Abstract]   [Full Text] [Related]  

  • 31. Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment.
    Hwang TJ; Keshavjee S
    PLoS Med; 2014 Sep; 11(9):e1001738. PubMed ID: 25268235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus on disease control objectives in the context of COVID-19 vaccines.
    Jain V; Tweed S
    Bull World Health Organ; 2021 May; 99(5):322. PubMed ID: 33958816
    [No Abstract]   [Full Text] [Related]  

  • 33. New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF.
    Ponnudurai N; Denkinger CM; Van Gemert W; Pai M
    J Epidemiol Glob Health; 2018 Dec; 8(3-4):103-105. PubMed ID: 30864749
    [No Abstract]   [Full Text] [Related]  

  • 34. The Collateral Damage of COVID-19.
    J Public Health (Oxf); 2020 Nov; 42(4):659. PubMed ID: 33236122
    [No Abstract]   [Full Text] [Related]  

  • 35. Challenges in Chronic Genetic Disorders: Lessons From the COVID-19 Pandemic.
    Pal S; Bhatia S; Bijarnia-Mahay S; Verma IC; Puri RD
    Indian Pediatr; 2021 Apr; 58(4):391-392. PubMed ID: 33883315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.
    Remme M; Martinez-Alvarez M; Vassall A
    Value Health; 2017 Apr; 20(4):699-704. PubMed ID: 28408014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On Answering the Call to Action for COVID-19: Continuing a Bold Legacy of Health Advocacy.
    Morgan RC; Reid TN
    J Natl Med Assoc; 2020 Dec; 112(6):675-680. PubMed ID: 32711898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COVID-19 pandemic has reinforced the need for community mental health-care models in Uganda.
    Mwesiga EK; Nakasujja N; Muhwezi WW; Musisi S
    Lancet Psychiatry; 2021 May; 8(5):362. PubMed ID: 33740413
    [No Abstract]   [Full Text] [Related]  

  • 39. Fadi Meroueh: responding to the health needs of prisoners.
    Bull World Health Organ; 2021 Jan; 99(1):8-9. PubMed ID: 33658731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different disease, same challenges: Social determinants of tuberculosis and COVID-19.
    Duarte R; Aguiar A; Pinto M; Furtado I; Tiberi S; Lönnroth K; Migliori GB
    Pulmonology; 2021; 27(4):338-344. PubMed ID: 33648891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.